Quantcast

Latest Oncology Stories

2014-09-04 16:28:00

Statement from Tim Turnham, Executive Director, Melanoma Research Foundation WASHINGTON, Sept. 4, 2014 /PRNewswire-USNewswire/ -- Today the FDA approved Keytruda (pembrolizumab), a new treatment for advanced melanoma, the deadliest form of skin cancer. Melanoma patients have been waiting anxiously for this day, given the promising data that early studies have shown. In clinical trials, 24 percent of patients taking pembrolizumab had their tumors shrink. Most of these patients...

2014-09-04 16:27:07

Unique Multivalent WT1 Vaccine to be developed across hematological malignancies and solid tumors NEW YORK, Sept. 4, 2014 /PRNewswire/ -- SELLAS Life Sciences Group (SELLAS), a Swiss-based development-stage biopharmaceutical company today announced that it has signed an exclusive global collaboration and license agreement with Memorial Sloan Kettering Cancer Center (MSK) for the development, marketing, and commercialization of MSK's proprietary WT1 cancer vaccine. "This...

2014-09-04 16:26:57

Wine brand kicks off 12th consecutive year of philanthropic fundraising NEW YORK, Sept. 4, 2014 /PRNewswire/ -- FAT bastard wines will once again support National Breast Cancer Awareness Month, continuing their dedication to help raise awareness and funds for the breast cancer cause. During the months of September and October, FAT bastard will donate 25 cents for every bottle of FAT bastard sold in restaurants and retail locations, up to $40,000. The launch of this year's campaign...

2014-09-04 08:30:46

Pennsylvania physicians say beating it begins with communications HARRISBURG, Pa., Sept. 4, 2014 /PRNewswire-USNewswire/ -- The simple fact of life for men is that as they age the risk of prostate cancer increases. And, it's one of those things that men cringe about. Statistics from the Centers for Disease Control and Prevention (CDC) show increasing risk as men age from their 50s into their 60s and then 70s. With the exception of skin cancer, the CDC says prostate cancer is the most common...

2014-09-04 08:30:25

BURLINGAME, Calif., Sept. 4, 2014 /PRNewswire/ -- Cleave Biosciences today announced that it has begun a Phase 1 clinical trial to evaluate its lead drug candidate, CB-5083, in patients with relapsed and refactory multiple myeloma. CB-5083 is a first-in-class, oral inhibitor of p97, a critical enzyme that controls various aspects of protein homeostasis. The open-label, Phase 1 dose escalation/dose expansion trial will evaluate the safety, pharmacokinetics, pharmacodynamics and...

2014-09-03 23:15:40

The Mesothelioma Victims Center says, "On July 10th, 2014 a significant portion of the US Capital Building was shut down because of possible asbestos exposure, and we want to emphasize the asbestos exposure would have been minimal, as opposed daily asbestos exposure US Navy Veterans, power plant workers, individuals in manufacturing or the trades were exposed to decades ago. We are urging individuals who had significant exposure to asbestos during the 1950's, 1960's,...

2014-09-03 23:05:54

Global research initiative to investigate long-term glioblastoma survivors. Chicago, IL (PRWEB) September 03, 2014 The American Brain Tumor Association (ABTA), in conjunction with the Brain Tumor Funder’s Collaborative (BTFC), is awarding a $2 million research grant to explore commonalities among long-term glioblastoma survivors around the world. Glioblastoma is a common and aggressive type of brain tumor most prevalent in adults ages 45-65, and affects more men than women. This highly...

2014-09-03 23:04:20

The Worthy Collection Partners with National Ovarian Cancer Alliance on Unique Fashion-for-Philanthropy Campaign New York, NY (PRWEB) September 03, 2014 -- Fashion-for-Fundraising Campaign Unites Apparel with Philanthropy to Support Ovarian Cancer, Help Save Women’s Lives -- This year, an estimated 22,000 women in the U.S. will get ovarian cancer, according to a just-published study by the American Cancer Society. Of these, two-thirds may die[1]. To honor National Ovarian Cancer...

2014-09-03 12:26:23

Leukemia Cup Regatta to Take Place September 20-21 at The San Francisco Yacht Club SAN FRANCISCO, Sept. 3, 2014 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society's (LLS) Greater Bay Area Chapter will be hosting its ninth annual Leukemia Cup Regatta on September 20-21, 2014 at The San Francisco Yacht Club (SFYC) in Belvedere, Calif. The event will begin with the VIP Dinner on September 20 with special guest speaker Wendy Schmidt, president of the Schmidt Family Foundation...

2014-09-03 08:34:23

WASHINGTON, Sept. 3, 2014 /PRNewswire/ -- The Florida Mesothelioma Victims Center is urging diagnosed victims in Florida, or their family members, to call them at 866-714-6466 to ensure they really are talking to the nation's most skilled mesothelioma attorneys, because when it comes to compensation for this asbestos exposure form of cancer quality really does matter. The Center's sense of urgency is once victims or their family members retain the services of an attorney to advance a...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related